Paolo Pucci

Insider Reports History

Entity
Individual
Location
C/O Arqule, Inc., 1 Wall Street, 6 Th Floor, Burlington, MA
Signature
/s/ Peter Silverman as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Paolo Pucci:

Stock Role Class Num Shares Value Price $ Report Date Ownership
WEST PHARMACEUTICAL SERVICES INC Director Common Stock 9.88K $3.54M $358.82 Apr 23, 2024 Direct
Merus N.V. Director Share Option (right to buy) 8.84K $120K $13.52 May 7, 2024 Direct
Replimune Group, Inc. Director Stock Option (right to buy) 32K Apr 1, 2024 Direct
Trillium Therapeutics Inc. Director Stock Option (Right to Buy) 0 Nov 17, 2021 Direct

Insider Reports Filed by Paolo Pucci

Symbol Company Period Transactions Value $ Form Type Date Filed Role
MRUS Merus N.V. May 7, 2024 1 $0 4 May 9, 2024 Director
WST WEST PHARMACEUTICAL SERVICES INC Apr 23, 2024 1 $0 4 Apr 25, 2024 Director
REPL Replimune Group, Inc. Apr 1, 2024 1 $0 4 Apr 3, 2024 Director
MRUS Merus N.V. Jun 8, 2023 1 $0 4 Jun 12, 2023 Director
WST WEST PHARMACEUTICAL SERVICES INC Apr 25, 2023 1 $0 4 Apr 27, 2023 Director
REPL Replimune Group, Inc. Apr 1, 2023 1 $0 4 Apr 4, 2023 Director
MRUS Merus N.V. May 31, 2022 1 $0 4 Jun 2, 2022 Director
WST WEST PHARMACEUTICAL SERVICES INC May 24, 2022 1 $0 4 May 26, 2022 Director
REPL Replimune Group, Inc. Apr 1, 2022 1 $0 4 Apr 5, 2022 Director
TRIL Trillium Therapeutics Inc. Nov 17, 2021 1 $0 4 Nov 19, 2021 Director
MRUS Merus N.V. May 28, 2021 1 $0 4 Jun 2, 2021 Director